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In the time since the publication of the IFT Expert Report [a report titled “Antimicrobial Resistance: Implications for the Food System” 
was published in 2006], governmental and inter-
governmental efforts to address the issue of 
antimicrobial resistance have seen much progress. 
In particular, concerns about the public-health 
implications of microbial resistance to antibiotics 
used in both human medicine and food-animal 
agriculture have led to the publication of the 
World Health Organization’s (WHO) List of 
Critically Important Antimicrobials for Human 
Medicine (see Table) and the World Organisation 
for Animal Health’s List of Antimicrobials of 
Veterinary Importance.
The U.S. Food and Drug Administration 
(FDA), which led with its own tables in 2003, has 
used such lists as the basis for categorizing various 
classes of antimicrobials as important, highly 
important, and critically important, and has since 
issued rules that prohibit most extra-label uses of 
some critically important antimicrobials such as 
fluoroquinolones and cephalosporins in food ani-
mal species. This report concludes that, although 
more remains to be done to improve the utility of 
these designations, such categorization of antimi-
crobials is helpful in prioritizing and addressing 
public-health concerns and antimicrobial use.
Global Monitoring Programs
Other efforts to address threats posed by antimi-
crobial resistance include monitoring programs for 
antimicrobial-resistant microbes that integrate 
human, animal, and food sampling schemes. These 
programs, in various stages of development and 
implementation worldwide, have been useful in 
identifying trends in development and persistence 
of antimicrobial resistance among select foodborne 
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Table. WHO listing (3rd revision, 2012) of critically important antimicrobials for human medicine
Critically Important Highly Important Important Unclassified
Aminoglycosides Amdinopenicillins Aminocyclitols Ionophores
Carbapenems and other penems Amphenicols Cyclic polypeptides Bambermycins
Cephalosporins (3rd and 4th generation)* Cephalosporins (1st and 2nd generation) Nitrofurantoins Carbadox
Cyclic esters Licomsamides Nitroimidazoles
Fluoro and other quinolones* Penicillins (anti-staphylococcal)
Glycopeptides* Pleuromutilins
Glycylcyclines Riminofenazines
Lipopeptides Steroid antibacterials
Macrolides and ketolides* Streptogramins
Monobactams Sulfonamides
Oxazolidinones Sulfones
Penicillins (natural aminopenicillins 
and antipseudomonal
Tetracyclines
Polymyxins
Rifamycins
Tuberculosis and other mycobacterial drugs
* The top 4 critically important antimicrobials are prioritized based on (1) high absolute number of people affected by diseases for which the antimicrobial is the sole or one of few alternatives to treat serious human disease 
and (2) high frequency of use of the antimicrobial for any indication in human medicine since usage may favor selection of resistance. In addition, a focusing criterion for the above classifications is that there is a greater 
degree of confidence that there are nonhuman sources that result in transmission of bacteria or their resistance genes to humans (WHO, 2012).
pathogens and related microbes. Two of 
the most mature such systems, the 
National Antimicrobial Resistance 
Monitoring System (NARMS) in the 
United States and the Danish Integrated 
Antimicrobial Resistance Monitoring 
and Research Program (DANMAP) in 
Denmark, were discussed in the 2006 
IFT Expert Report. NARMS, a joint 
program administered by the FDA, 
Centers for Disease Control and 
Prevention (CDC), and U.S. Dept. of 
Agriculture has, during a roughly 
14-year period, monitored trends in 
antimicrobial resistance among food-
borne pathogens such as Salmonella and 
Campylobacter jejuni that are largely of 
animal origin.
This update discusses developments 
in the NARMS program since publica-
tion of the parent IFT report in 2006. In 
addition, general observations from 
NARMS data are presented, including 
the lack of resistance expansion to some 
of the WHO critically important antibi-
otics, such as fluoroquinolone and 
quinolone resistance among non-Typhi 
Salmonella serovars; an increase in fluo-
roquinolone-resistance among C. jejuni 
followed by a sustained level (neither 
increase nor decrease) after fluoroquino-
lone use was banned for poultry; very 
low levels of C. jejuni resistance to mac-
rolides; and markedly increasing 
resistance among Salmonella to third-
generation cephalosporins. Many 
multidrug resistance (MDR) phenotypes 
(with or without ceftiofur resistance) 
among Salmonella are serovar-dependent, 
with the most prevalent being S. 
Newport and S. Typhimurium in cattle, 
and S. Heidelberg and S. Kentucky in 
poultry. 
MRSA
Also of note since the publication of the 
Expert Report in 2006 is substantial 
interest and questions surrounding the 
emerging resistant pathogen methicillin-
resistant Staphylococcus aureus (MRSA). 
The increasing incidence of community- 
and occupational-based infections due to 
MRSA continues to vex public-health 
practitioners. In recent years, questions 
have been raised about the potential for 
foodborne transmission of this pathogen 
and the role of agricultural antimicrobial 
use in its emergence. This update dis-
cusses pertinent issues and research 
related to this topic and concludes that, 
at present, there is little empirical evi-
dence to support its direct relevance to 
food safety or to infer that antibiotic use 
in agriculture has played a primary role 
in its emergence and evolution. 
In addition to methicillin resistance 
in S. aureus, increases have been observed 
in bacterial resistances to multiple anti-
microbials since 2006. These increases 
in co-resistance, that is tolerance to 
therapeutic concentrations of more than 
one antibiotic, complicate the challenge 
of treating drug-resistant bacteria by 
potentially delaying the selection and 
application of the most efficacious antibi-
otics which may result in adverse 
public-health outcomes. Co-resistance 
can be conferred by accumulation and 
genetic linkage of multiple gene cassettes 
such as that observed on the IncA/C 
plasmid of Enterobacteriaceae. Acquisition 
of the IncA/C plasmid is of most con-
cern because of the plasmid’s ability to 
acquire large numbers and varieties of 
determinants conferring drug resis-
tance. This plasmid seems to have a 
broad host range that enables it to circu-
late among a variety of bacterial hosts, 
both commensals and pathogens. One 
such example of IncA/C plasmid 
pg 44 03.13  •  www.ift.org
Read the Full 
Report Online
The IFT Scientific Status Summary 
“Antimicrobial Resistance: Challenges 
and Perspectives” is published in the 
March 2013 issue of Comprehensive 
Reviews in Food Science and Food Safety. 
To read the full report, please visit http://
onlinelibrary.wiley.com/journal/10.1111/%
28ISSN%291541-4337. This and other 
Scientific Status Summaries are prepared 
by the Institute of Food Technologists as 
one source of accurate and objective 
information suitable for many different 
audiences, including IFT members. 
Scientific Status Summaries are rigor-
ously peer-reviewed by individuals with 
specific expertise in the subject.
Antimicrobial Resistance 
and Food Animals
acquisition is by Salmonella Newport MDR-
AmpC. This serovar is a highly virulent 
pathogen of special concern because it is not 
only resistant to ceftriaxone that is the drug 
of choice for treating salmonellosis in chil-
dren but is also co-resistant to many 
alternative drugs.
Co-selection and Co-resistance
In addition to antimicrobials, many non-anti-
microbial factors such as metals and 
disinfectants can co-select for antimicrobial 
resistance in bacteria. Indeed, the use of 
heavy metals as replacements for antimicro-
bial growth promotants in Europe, such as 
elevated levels of feed-grade zinc and copper, 
have been implicated in helping to expand 
and sustain MRSA and macrolide- and van-
comycin-resistant Enterococcus spp., 
respectively. Pertinent issues surrounding 
co-resistance and co-selection as well as the 
implications of these issues for the develop-
ment of effective interventions are discussed 
in detail in this report. 
Some antimicrobial-resistant bacteria are 
clearly a foodborne threat (for example, 
Salmonella Typhimurium DT104), whereas 
others are less likely to be a foodborne haz-
ard (livestock-associated MRSA). Likewise, 
the role that agricultural antimicrobial selec-
tion pressures have played in promoting the 
emergence and persistence of such strains is 
perhaps more clear for the former than the 
latter. Regardless, the issue of co-selection 
by other contributing factors, including met-
als and disinfectants, and the 
serovar-dependence of resistance traits 
among the Salmonella create considerable 
uncertainty of the magnitude of risk posed 
by animal and aquaculture uses of these 
products.
Intervention Approaches
Perhaps because of the complexity and 
uncertainty associated with co-resistance 
and co-selection, there is little consensus on 
what constitutes an effective intervention to 
mitigate the occurrence of resistance among 
microorganisms, especially those of public-
health relevance. One approach is to reduce 
or prohibit the use of antimicrobials in agri-
cultural animals. This strategy has been 
successful for specific “drug-bug-use” combi-
nations, such as when broiler producers in 
Quebec ceased the in ovo administration of 
ceftiofur. This intervention appears to have 
contributed to meaningful reductions in the 
occurrence of ceftiofur-resistant S. 
Heidelberg and Escherichia coli on poultry 
products and in the percentage of ceftiofur-
resistant S. Heidelberg in human clinical 
patients.
However, in other situations, more com-
plex interventions appear to be required. 
Studies evaluating the Danish experience, 
wherein non-therapeutic uses of antimicrobi-
als were excluded from livestock production 
in Denmark, have shown minimal evidence 
to date suggesting that this intervention has 
provided substantially greater public-health 
protection in the form of a reduced disease 
burden of morbidity and mortality in the 
human population. Furthermore, the Danish 
experience illustrates that simple interven-
tions are, in some cases, insufficient to 
impact resistance levels and associated health 
outcomes and, further, that metrics of suc-
cess may be difficult to measure, particularly 
if they are not proximate in terms of time or 
space to the intervention.
Imported Foods
While domestic control over antimicrobial 
usage policy and monitoring is achievable, 
little actionable risk management informa-
tion is available for imported foods. Because 
of the recognized global concern of antimi-
crobial resistance in the food supply and the 
potential for these resistant organisms to be 
moved around the globe in foods, the Codex 
Alimentarius Commission (CODEX) estab-
lished an ad hoc Intergovernmental Task 
Force on Antimicrobial Resistance in 2007. 
The Task Force had the mandate to provide 
guidelines for a structured risk analysis 
framework to address human health risks 
associated with the presence of antimicro-
bial-resistant microorganisms in food and 
animal feed, including aquaculture, and the 
transmission through food and animal feed 
of antimicrobial-resistant microorganisms or 
determinants linked to the nonhuman use of 
antimicrobial agents. Through this venue, 
national and regional food safety authorities 
may soon have increased ability to assess and 
control risks posed by antimicrobial resis-
tance in imported foods. 
Saliently, the prevalence and diversity of 
resistance to different antimicrobials can 
vary greatly among countries and regions, 
and this might be due to substantive differ-
ences in antimicrobial usage practices. While 
we must focus on ensuring that antimicro-
bial use within the U.S. is prudent and also 
continue to discover and evaluate alterna-
tives to antimicrobial use, we also must 
recognize that food production is interna-
tionally interdependent.
It is highly likely that actions will be 
taken during the next five years to further 
restrict the availability of critically important 
antimicrobials and their allowed uses in 
aquaculture and agriculture, particularly in 
the developed world. However, such prac-
tices may in the near future have trade 
implications which will apply pressures to 
those jurisdictions with less control on their 
antimicrobial practices to develop and imple-
ment appropriate risk management policies. 
To effectively mitigate harmful effects from 
antimicrobial resistance in the U.S., we 
must work with global partners to promote 
prudent use in those countries where regula-
tory oversight of critically important 
antimicrobial drugs is underdeveloped. FT
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